Amgen litigation: TP risks can extend far beyond tax compliance
15 May 2023
Paul Sutton
The Amgen class action law suit shows the potential impact of TP risks on M&A On 13 March 2023, a claim was filed against Amgen Inc, the biopharmaceutical group, as part of a proposed class action by investors. It’s an interesting example of how the management of TP risks can have far wider implications than…